Form 4: Quest Diagnostics Executive Sells Shares to Cover Tax Obligations and Under 10b5-1 Plan
SEC Form 4 Filing
Catherine T. Doherty, EVP at Quest Diagnostics, sold shares to cover tax obligations and under a pre-arranged 10b5-1 sales plan.
Summary
- Catherine T. Doherty, an Executive Vice President at Quest Diagnostics, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- On February 26, 2025, she disposed of 455 shares of common stock to cover tax withholding obligations arising from the vesting of restricted stock units at a price of $171.75 per share.
- On February 27, 2025, she sold 824 shares of common stock at a price of $172.61 per share, pursuant to a Rule 10b5-1 sales plan.
- Following these transactions, Doherty directly owns 69,178 shares of Quest Diagnostics common stock.
- She also indirectly owns 4,428 shares through the company's 401(k)/SDCP.
Sentiment
Score: 5
Explanation: The filing reflects routine transactions related to tax obligations and a pre-arranged sales plan, indicating a neutral sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. Sales under 10b5-1 plans are often pre-arranged to avoid accusations of insider trading.
Key Dates
| Date | Description |
|---|---|
| 02/26/2025 | Disposition of 455 shares to cover tax withholding obligations. |
| 02/27/2025 | Sale of 824 shares pursuant to a Rule 10b5-1 sales plan. |
| 02/28/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.